School-Located Vaccination Clinics Reports
AIM and the National Association of School Nurses (NASN) released reports detailing school-located vaccination clinics (SLVs) roles during COVID-19.
Health Equity: Methods to Support Communities
This iREACH and P4VE webinar featured a presentation from Dr. Dan on health equity-centered methods and strategies to help you communicate with and educate your communities about flu and COVID-19 vaccines.
Monoclonal Antibodies for COVID-19 Disease
This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on monoclonal antibodies: what they are, how they work, and how they should be used.
Talking Points: Full FDA Approval – Pfizer COVID-19 Vaccine
This e-learning module was developed by the iREACH team to provide a suite of materials containing comprehensive information on flu disease and flu vaccine.
AIM: Fertility, Pregnancy, and COVID-19 Vaccines Talking Points
This talking points document was developed by iREACH Subject Matter Experts to provide information on fertility, pregnancy and COVID-19 vaccines.
FDA Authorized vs FDA Approved
This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide information on the difference between vaccines that have been authorized by the FDA vs. approved by the FDA.
Adolescent Immunization Toolkit
With the recent authorization and recommendation of vaccines for use in children ages 6 months through 4 years, the nation’s public health programs…
Public Comment: July 22, 2021 ACIP Emergency Meeting
Since the beginning of pandemic, immunization program managers have been working long days, nights, and weekends to address the many challenges of vaccinating the nation. The success and impact of this vaccine campaign are nothing short of miraculous.
CommuniVax Releases Guidance for COVID-19 Vaccination Informed by Communities of Color
The CommuniVax Coalition has released a new report, Carrying Equity in COVID-19 Vaccination Forward: Guidance Informed by Communities of Color, to inform this work.
AIM: Talking Points About GBS and J&J Vaccine
This talking points document was developed by iREACH Subject Matter Experts to provide information on the few cases of GBS reported in individuals who received the J & J COVID-19 vaccines.